Cargando…
PIPAC for Gastrointestinal Malignancies
The peritoneum is a common site of metastases for gastrointestinal tumors that predicts a poor outcome. In addition to decreased survival, peritoneal metastases (PMs) can significantly impact quality of life from the resulting ascites and bowel obstructions. The peritoneum has been a target for regi...
Autores principales: | Daniel, Sara K., Sun, Beatrice J., Lee, Byrne |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10650315/ https://www.ncbi.nlm.nih.gov/pubmed/37959264 http://dx.doi.org/10.3390/jcm12216799 |
Ejemplares similares
-
Pressurized IntraPeritoneal Aerosol Chemotherapy (PIPAC) for the treatment of malignant mesothelioma
por: Giger-Pabst, Urs, et al.
Publicado: (2018) -
In search of evidence – PIPAC on the fast lane
por: Hübner, Martin
Publicado: (2018) -
Nab-PIPAC: a phase IB study protocol of intraperitoneal cisplatin and nab-paclitaxel administered by pressurised intraperitoneal aerosol chemotherapy (PIPAC) in the treatment of advanced malignancies confined to the peritoneal cavity
por: Lang, Noemie, et al.
Publicado: (2023) -
Feasibility and Safety of Taxane-PIPAC in Patients with Peritoneal Malignancies—a Retrospective Bi-institutional Study
por: Mehta, Sanket, et al.
Publicado: (2022) -
Pressurized intraperitoneal aerosol chemotherapy (PIPAC) for peritoneal malignancy: initial experience of the first program in the Baltic countries
por: Račkauskas, Rokas, et al.
Publicado: (2021)